Business
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
BURLINGAME, Calif., February 19, 2026--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 at
About this update from Innoviva, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/d2f09ad1e873b625a5ad9464f1ab6805"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ERbQygU4QN5SINZeFyk9BQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d2f09ad1e873b625a5ad9464f1ab6805","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/tLxFTUfn6S77aYVDnebKoA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/d2f09ad1e873b625a5ad9464f1ab6805","width":1024,"height":512}},"lazy":false},{"type":"text","content":"BURLINGAME, Calif., February 19, 2026--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in a fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 at 10:00 a.m. E.T. The conference will be held virtually.","length":602,"tagName":"p"},{"type":"text","content":"A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investor Relations section of the Company’s website at https://investor.inva.com/presentations-events. An archived replay of the webcast will be available following the fireside chat date.","length":292,"tagName":"p"},{"type":"text","content":"About Innoviva","length":14,"tagName":"p"},{"type":"text","content":"Innoviva is a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets. Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited ("GSK"). Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and cr...